Search Result "BID NVP"
Once-a-Day (QD) vs Twice-Daily (BID) Nevirapine as Simplification in PITreated Patients After 2 mos. of BID Induction
Journal: Current HIV Research
Volume: 9 Issue: 3 Year: 2011 Page: 166-173
Author(s): Renato Maserati, Micaela Brandolini, Annamaria Cattelan, Anna Orani, Laura Sighinolfi, Massimo Andreoni, Alessia Uglietti, Giovanni Guaraldi, Giovanni Sotgiu
New Targeted Therapies for Anaplastic Thyroid Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 87-93
Author(s): Alessandro Antonelli, Poupak Fallahi, Salvatore Ulisse, Silvia Martina Ferrari, Michele Minuto, Giovanna Saraceno, Francesca Santini, Valeria Mazzi, Massimo DArmiento, Paolo Miccoli
Pharmacokinetic Drug-Drug Interactions Involving Antiretroviral Agents: An Update
Journal: Current Drug Metabolism
Volume: 24 Issue: 7 Year: 2023 Page: 493-524
Author(s):
Lipid Changes Associated with Antiretroviral Therapy: Results Differ by Reporting Approach
Journal: Current HIV Research
Volume: 7 Issue: 5 Year: 2009 Page: 547-554
Author(s): Wanda Lakey, Charles Hicks
Hepatotoxicity of Antiretroviral Drugs
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 3697-3710
Author(s): N. Abrescia, M. DAbbraccio, M. Figoni, A. Busto, A. Maddaloni, M. D. Marco
Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria
Journal: Current HIV Research
Volume: 13 Issue: 3 Year: 2015 Page: 201-209
Author(s): Holly E. Rawizza,Charlotte A. Chang,Beth Chaplin,Isah A. Ahmed,Seema T. Meloni,Tinuade Oyebode,Bolanle Banigbe,Atiene S. Sagay,Isaac F. Adewole,Prosper Okonkwo,Phyllis J. Kanki,the APIN PEPFAR Team
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 7 Year: 2011 Page: 593-599
Author(s): Alexander Schultze, Walter Fiedler
The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs
Journal: Clinical Cancer Drugs
Volume: 1 Issue: 2 Year: 2014 Page: 100-115
Author(s): Antonello Di Paolo,Guido Bocci,Romano Danesi
The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7 Issue: 2 Year: 2012 Page: 113-128
Author(s): Roberta Agabio,Paola Maccioni,Mauro A.M. Carai,Gian Luigi Gessa,Wolfgang Froestl,Giancarlo Colombo
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2686-2714
Author(s): S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke, P. Workman